Karlyn Martin

🩸doctor, thrombosis researcher, 🎾 player, 🦮🐕‍🦺

[Karlyn Martin @MarKar24]

Charles Mininger @NUFeinbergMed and I discuss how we talk about patients with #SickleCell in @JournalGIM read it here: https://t.co/Y3KKepVd1Q

[Karlyn Martin @MarKar24]

@kush_r_desai @heatherlgornik @GBarnesMD @connors_md @MaryCushmanMD @IsthPresident @SVM_tweets *an
Twitter novice 🙂

[Karlyn Martin @MarKar24]

@kush_r_desai @heatherlgornik @GBarnesMD @connors_md @MaryCushmanMD @IsthPresident @SVM_tweets Yes- there was a abstract presented at ASH last weekend- about double odds of VTE compared with heterozygous PTGM or het FVL alone

[Sakshi Jasra @sjasraMD]

Dream Heme team at #ASH23. But missing @MaryCushmanMD

@UVMDeptMed @UVMcancercenter

[Karlyn Martin @MarKar24]

Learning about PE AND how to take a selfie! Thanks ⁦@RosovskyRachel⁩ and #PERT2023 for a great conference!

[Karlyn Martin @MarKar24]

Wearing my ⁦@AnticoagForum⁩ compression stockings on flight home from #Azores 😎☀️
AnticoagForum around the 🌍!

[Karlyn Martin @MarKar24]

Great working with @KSanfilippoMD @RosovskyRachel @SCWollerMD @Lbkreuziger to report similar outcomes in low weight patients treated with DOAC vs Warfarin for VTE!
https://t.co/rP4YqufrKY

[Karlyn Martin @MarKar24]

Father daughter 🎾 National champions ! (Super senior division 😉)

[Karlyn Martin @MarKar24]

AddThis | Home https://t.co/QSzCNolJmJ

[Vasculearn Network @Vasculearn]

Apixaban, dabigatran, and warfarin - oh my! Looking for a quick & convenient way to compare different #DOACs & #warfarin?! Look no further than NATF's #anticoagulation comparison chart! See the full chart at https://t.co/bGJMf3uoD4

[Karlyn Martin @MarKar24]

Blood cells circulating at #ASH2022 party 😁

[Marc Carrier @MarcCarrier1]

Frequent reason for consultation: What is the risk of bleeding for patients with elevated INR from chronic liver disease compared to those on warfarin?
@KSanfilippoMD @JTHjournal
https://t.co/OvUD5OKfJj

[Society of Interventional Radiology @SIRspecialists]

This month's SIR Scan's graphic is from the IR Quarterly article "The COVID-CLOT connection: A review of thrombotic complications associated with #COVID19." Check out the design by Drs. Karlyn Martin and @kush_r_desai and read the full article. #IRad https://t.co/ez9qBZP1Te

[Hanny Al-Samkari, MD @HannyAlSamkari]

Names matter. Thrilled to share this Viewpoint we just published in @TheLancetHaem making the case that we should embrace the term "Classical Hematology" over "Benign" or Non-Malignant". Honored to have written this with Drs. Alison Loren and Alfred Lee!

https://t.co/nSHGfqRDU7

[Karlyn Martin @MarKar24]

Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis - Khan - - Journal of Thrombosis and Haemostasis https://t.co/pnAMruywp1

[Karlyn Martin @MarKar24]

Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis: Annals of Internal Medicine: Vol 0, No 0 https://t.co/RZGA2nQyNh

[Karlyn Martin @MarKar24]

Op-Ed: As a doctor in a COVID unit, I'm running out of compassion for the unvaccinated. Get the shot - Los Angeles Times https://t.co/DBcwVu6pV4

[Kristen Sanfilippo @KSanfilippoMD]

Studies show extended dosing of DOACs at therapeutic and prophylactic dosing reduce risk of recurrent VTE (NEJM 2013 & 2017). Do you do this? Take our survey to inform practice patterns!
@NicoleKuderer @jzbos @connors_md @tzufeiwang
https://t.co/kcsiWrbPGj

[Karlyn Martin @MarKar24]

What happened to the “flatten the curve” rally cry 😔

[Karlyn Martin @MarKar24]

@SchimmelHeart Were antiXa levels therapeutic?